Literature DB >> 5421784

Parkinsonism, L-dopa and mental depression.

M Cherington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5421784     DOI： 10.1111/j.1532-5415.1970.tb02784.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  8 in total

Review 1.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

4.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

5.  Apomorphine and psychopathology.

Authors:  S Lal; C E De la Vega
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

6.  Depression in Parkinson disease: a disabling but neglected factor.

Authors:  R Cantello; A Riccio; L Scarzella; D Leotta; B Bergamasco
Journal:  Ital J Neurol Sci       Date:  1984-12

Review 7.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

8.  Does levodopa alter depression and psychopathology in Parkinsonism patients?

Authors:  G G Marsh; C H Markham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.